Tag: adamis pharmaceuticals
November 24, 2019
5 Top NASDAQ Biotech and Pharma Stocks: Fulcrum Climbs 73 Percent
Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have... August 28, 2019
Adamis Pharmaceuticals Provides Launch and Marketing Update
Adamis Pharmaceuticals (NASDAQ:ADMP) has announced a progress report and marketing update for the US launch of SYMJEPI injections. As quoted... January 17, 2019
Adamis’ Commercial Partner Launches SYMJEPI (epinephrine) in the US
Adamis Pharmaceuticals (NASDAQ:ADMP) today announced that its marketing and commercial partner, Sandoz, a Novartis division, has launched SYMJEPI (epinephrine) 0.3 mg...
January 2, 2019
Adamis Submits NDA for New Product
The application was for Adamis’ naloxone pre-filled single dose syringe (PFS) product candidate, as a treatment for opioid overdose. January 2, 2019
Adamis Pharmaceuticals Submits New Drug Application to FDA for Its Naloxone Pre-Filled Syringe
Adamis Pharmaceuticals (NASDAQ:ADMP) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration for... December 6, 2018
Adamis Pharmaceuticals Provides Update on the U.S. Launch of SYMJEPI
Adamis Pharmaceuticals (NASDAQ:ADMP) today provided a business update announcing the U.S. launch of FDA-approved SYMJEPI (epinephrine) 0.3mg Injection is planned for...
October 7, 2018